Pharming Group N.V.
PHAR · Pharmaceutical Preparations
Latest available SEC filing: 20-F/A ·
Latest disclosures
-
Form 20-F/A
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PHAR · 71716E105 - Ordinary Shares / American Depositary Shares
Company details and SEC sources
CIK 0001828316 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PHAR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Darwinweg 24, Leiden, Netherlands, 2333 CR
- Incorporated in
- Netherlands
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields